Abstract
Background
Macrophages are known to play a crucial role in the chronic inflammation associated with Chronic Obstructive Pulmonary Disease (COPD). BML-111, acting as a lipoxin A4 (LXA4) receptor agonist, has shown to be effective in protecting against COPD. However, the precise mechanism by which BML-111 exerts its protective effect remains unclear.
Methods
In order to establish a cell model of inflammation, cigarette smoke extract (CSE) was used on the RAW264.7 cell line. Afterwards, an Enzyme-linked immunosorbent assay (ELISA) kit was employed to measure concentrations of tumor necrosis factor-α (TNF-α), interleukin-1beta (IL-1β), interleukin-18 (IL-18), and interleukin-10 (IL-10) in the cell supernatants of the RAW264.7 cells.In this study, we examined the markers of macrophage polarization using two methods: quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot analysis. Additionally, we detected the expression of Notch-1 and Hes-1 through Western blotting.
Results
BML-111 effectively suppressed the expression of pro-inflammatory cytokines TNF-α, IL-1β, and IL-18, as well as inflammasome factors NLRP3 and Caspase-1, while simultaneously up-regulating the expression of the anti-inflammatory cytokine IL-10 induced by CSE. Moreover, BML-111 reduced the expression of iNOS, which is associated with M1 macrophage polarization, and increased the expression of Arg-1, which is associated with M2 phenotype. Additionally, BML-111 downregulated the expression of Hes-1 and the ratio of activated Notch-1 to Notch-1 induced by CSE. The effect of BML-111 on inflammation and macrophage polarization was reversed upon administration of the Notch-1 signaling pathway agonist Jagged1.
Conclusion
BML-111 has the potential to suppress inflammation and modulate M1/M2 macrophage polarization in RAW264.7 cells. The underlying mechanism may involve the Notch-1 signaling pathway.
Abbreviations
COPD, Chronic obstructive pulmonary disease; LXA4, Lipoxin A4; CSE, Cigarette smoke extract; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-18, interleukin 18; NLRP3, NOD-like receptor thermal protein domain associated protein 3; iNOS, inducible nitric oxide synthase; Arg-1, Arginase-1; Dex, Dexamethasone; LOXs, lipoxygenases; ASC, apoptosis-associated spot-like protein containing a card; GM-CSF, granulocyte-macrophage colony-stimulating factor; LPS, lipopolysaccharide; IFN-γ, interferon-γ.
Data Sharing Statement
The analyzed data sets generated during the present study are available from the corresponding author.
Ethics Approval
All experimental work was approved by Medical Ethics Committee of Second Affiliated Hospital of Nanchang University.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Project number: 81460002, 81960012, 81860349, 82260374), the Natural Science Foundation of Jiangxi province in China (Project number:20202BAB206038).
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Disclosure
The authors declare that they have no competing interests.